Major Depressive Episode: Clinical Trials

73 trials for Major Depressive Episode, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 18 recruiting, 8 terminated, 8 unknown. 28 Not applicable, 12 Phase 2, 8 Phase 3, 7 Phase 1, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 13, Recruiting 8, Unknown 4, Terminated 2, Active not recruiting 1
Phase 212Completed 6, Terminated 4, Unknown 2
Phase 38Completed 3, Recruiting 2, Terminated 2, Not yet recruiting 1
Phase 17Completed 5, Recruiting 1, Withdrawn 1
Phase 45Completed 4, Terminated 1

Follow Major Depressive Episode: new trials by email Literature Review of Major Depressive Episode trials Research Report on Major Depressive Episode

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive Episodes
Oral ketamine, Oral midazolam - Major Depressive Episode
Phase 3Not yet recruitingJawaharlal Institute of Postgraduate Medical Education & Research2202026-10-012026-10-01
Signature Response to Light Therapy in Unipolar and Bipolar Major Depressive Episode (MDE)
Light therapy - Major Depressive Episode
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris1732026-06-172026-08-12
tDCS: Sleep to Mood in Depression (S2M-D)
transcranial direct current stimulation (tDCS) - Major Depressive Disorder, MDD
Not applicableRecruitingNYU Langone Health352026-06-042026-06-08
Remote Medical Monitoring of Patients With Depression
Use of ThIA Medical Device - Depression Chronic, Depression and Quality of Life
Phase 1RecruitingThIA Santé Mentale6082026-04-012026-10-16
EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT
Electroconvulsive Therapy - Major Depression Moderate, Major Depression Severe
RecruitingIstanbul University - Cerrahpasa622026-01-012026-08-05
EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
Electroconvulsive Therapy - Major Depression Moderate, Major Depression Severe
RecruitingIstanbul University - Cerrahpasa622025-12-012026-07-31
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
60Hz Intermittent Light Therapy, Sham Light Therapy - Depression, MDD
Not applicableRecruitingNYU Langone Health402025-08-182026-06-29
Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
MagPro X100 edition (MagVenture, Skovlunde, Denmark) - Major Depressive Disorder, Depression in Adolescence
Not applicableRecruitingUniversity of Texas at Austin402025-04-012026-08-19
Personalized Ultrasonic Brain Stimulation for Depression (R61)
LTFUS to SCC, LTFUS to ALIC - Major Depressive Episode, Depression - Major Depressive Disorder
Phase 1 / Phase 2CompletedBrian Mickey392025-03-102026-11-03
The Impact of Coach-guided Risk Communication on the Risk of Major Depression
coach-guided personalized depression risk communication, depression risk information - Major Depressive Episode, Risk Reduction
Not applicableRecruitingDalhousie University10002025-02-102025-09-02
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
Major Depressive Disorder (MDD), Major Depressive Episode
RecruitingUnity Health Toronto2002024-12-162024-12-13
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
Ketamine, Placebo - Major Depressive Episode
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris602024-10-202025-09-03
At-Home tDCS as Maintenance Therapy
tDCS - MDD, Severe Depression
Not applicableRecruitingTechnical University of Munich302024-10-012025-12-08
A Text Messaging Intervention to Reduce Perinatal Depression Risk
Text Messaging Intervention - Major Depressive Episode
Not applicableCompletedUniversity of Massachusetts, Worcester402024-09-052026-01-27
SAINT for MDD in an Inpatient Setting Follow-on
Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode
Phase 2 / Phase 3TerminatedMagnus Medical22024-06-302025-03-24
The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition
Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode
Phase 2 / Phase 3TerminatedMagnus Medical22024-06-302025-03-24
Sensation Seeking and TMS Response in TRD
Transcranial Magnetic Stimulation (TMS) - MDD, Severe Depression
RecruitingTechnical University of Munich1002024-05-022026-10-22
Metabolomics During ElectroConvulsivoTherapy
Electroconvulsive therapy - Major Depressive Episode, ECT
Not applicableRecruitingHôpital le Vinatier502024-03-112025-07-24
Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
Intermittent Theta Burst Transcranial Magnetic Stimulation (Active), Intermittent Theta Burst Transcranial Magnetic Stimulation (Sham) - Major Depressive Episode, Borderline Personality Disorder
Not applicableCompletedMassachusetts General Hospital752023-11-012026-07-14
Presynaptic Imaging in Major Depressive Episodes After COVID-19
[11C]DTBZ PET scan, [18F]SDM8 PET scan, MRI scan - Long COVID, Major Depressive Disorder
RecruitingCentre for Addiction and Mental Health902023-08-222026-02-11

Showing 20 of 73. Sign in to see all of them.

Narrower conditions

Depression (27)  ·  Depressive Disorder, Major (25)  ·  Bipolar Disorder (12)  ·  Depressive Disorder, Treatment-Resistant (9)  ·  Depressive Disorder (6)  ·  Suicide (6)  ·  Suicidal Ideation (5)  ·  Psychological Well-Being (3)  ·  Anhedonia (2)  ·  Borderline Personality Disorder (2)  ·  Recurrence (2)  ·  Acute Coronary Syndrome (1)  ·  Breast Neoplasms (1)  ·  COVID-19 (1)  ·  Catatonia (1)

Broader conditions

Mental Disorders (39)  ·  Mood Disorders (37)  ·  Behavior (32)  ·  Behavioral Symptoms (31)  ·  Depressive Disorder (25)  ·  Bipolar and Related Disorders (12)  ·  Self-Injurious Behavior (9)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (5)  ·  Suicide (4)  ·  Disease Attributes (3)  ·  Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Personal Satisfaction (3)

Interventions

Ketamine (10)  ·  Midazolam (6)  ·  Transcranial Magnetic Stimulation (4)  ·  Blood Specimen Collection (3)  ·  Electroconvulsive Therapy (3)  ·  Sodium Chloride (3)  ·  Citalopram (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Psychotherapy (2)  ·  Transcranial Direct Current Stimulation (2)  ·  Antipsychotic Agents (1)  ·  Botulinum Toxins, Type A (1)  ·  Buprenorphine (1)  ·  Citric Acid (1)  ·  Esketamine (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (5)  ·  University Hospital, Montpellier (5)  ·  Centre for Addiction and Mental Health (3)  ·  Freie Universität Berlin (2)  ·  Istanbul University - Cerrahpasa (2)  ·  Jiangsu Province Nanjing Brain Hospital (2)  ·  Magnus Medical (2)  ·  NYU Langone Health (2)  ·  New York State Psychiatric Institute (2)  ·  Technical University of Munich (2)  ·  University of British Columbia (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  AstraZeneca (1)  ·  Biogen (1)  ·  Bo Hu (1)

Countries

United States (24)  ·  France (14)  ·  Canada (10)  ·  Germany (7)  ·  Australia (4)  ·  China (3)  ·  Ireland (2)  ·  Taiwan (2)  ·  Turkey (Türkiye) (2)  ·  Austria (1)  ·  India (1)  ·  Russia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Amit Anand, MD (2)  ·  Brandon Bentzley, MD (2)  ·  Declan M McLoughlin, PhD (2)  ·  Emilie Olie, MD PhD (2)  ·  Fei Wang (2)  ·  Fidel Vila-Rodriguez, MD, PhD (2)  ·  Alla Avedisova, Prof (1)  ·  Anatoly Smulevich, Prof (1)  ·  Anthony Rodgers (1)  ·  Brian J Mickey (1)  ·  Brian J Mickey, MD, PhD (1)  ·  Charles Nduka, MA, MD, FRCS (1)

Results publications

PMID 10735328, PMID 11940851, PMID 1260078, PMID 12827140, PMID 13688369, PMID 17474805, PMID 18291293, PMID 21041614, PMID 22123153, PMID 22858219, PMID 23588951, PMID 23809145, PMID 24337537, PMID 24602409, PMID 25592385, PMID 25629589, PMID 27028832, PMID 28636705, PMID 28739263, PMID 28939116, PMID 28969438, PMID 29269262, PMID 29436330, PMID 29536616, PMID 30124867, PMID 30572160, PMID 31675086, PMID 31881995, PMID 33087184, PMID 34131914, PMID 34510411, PMID 34739064, PMID 35036831, PMID 35944722, PMID 36209675, PMID 36301615, PMID 37224232, PMID 37361338, PMID 37817124, PMID 37891643, PMID 37974160, PMID 38619842, PMID 38867362, PMID 38968425, PMID 39428602, PMID 39551735, PMID 39696180, PMID 39731725, PMID 39884877, PMID 40669702

NIH funding

2019 (2), 2016 (1), 2023 (1), R01MH125160 (1), R34MH130934 (1), R61MH134943 (1)